Home Applications 208956 Application 208956
Type NDA
Sponsor ARBOR PHARMS LLC Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 TRIPTODUR KIT TRIPTORELIN PAMOATE FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR EQ 22.5MG BASE/VIAL Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N208956-001 TRIPTODUR KIT TRIPTORELIN PAMOATE EQ 22.5MG BASE/VIAL FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR RLD, RS 2017-06-29
Orange Book patents# Current patent rows page 1 of 1 · 1 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N208956-001 10166181 2029-06-30 Drug product 2019-01-25
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 2 of 2 · 45 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N208956-001 TRIPTODUR KIT EQ 22.5MG BASE/VIAL FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR RLD, RS 2017-06-29 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N208956-001 TRIPTODUR KIT EQ 22.5MG BASE/VIAL FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR RLD, RS 2017-06-29 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N208956-001 TRIPTODUR KIT EQ 22.5MG BASE/VIAL FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR RLD, RS 2017-06-29 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N208956-001 TRIPTODUR KIT EQ 22.5MG BASE/VIAL FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR RLD, RS 2017-06-29 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N208956-001 TRIPTODUR KIT EQ 22.5MG BASE/VIAL FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR RLD, RS 2017-06-29 a50c72e98297…
Observed Orange Book patent history# Patent history page 1 of 2 · 45 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-11-14 07:37:17 2026-10 N208956-001 10166181 2029-06-30 Drug product 2019-01-25 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N208956-001 10166181 2029-06-30 Drug product 2019-01-25 c2088c7a36db…2026-09-14 22:38:34 2026-08 N208956-001 10166181 2029-06-30 Drug product 2019-01-25 84e616aacf4f…2026-08-18 06:07:40 2026-07 N208956-001 10166181 2029-06-30 Drug product 2019-01-25 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N208956-001 10166181 2029-06-30 Drug product 2019-01-25 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N208956-001 10166181 2029-06-30 Drug product 2019-01-25 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N208956-001 10166181 2029-06-30 Drug product 2019-01-25 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N208956-001 10166181 2029-06-30 Drug product 2019-01-25 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N208956-001 10166181 2029-06-30 Drug product 2019-01-25 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N208956-001 10166181 2029-06-30 Drug product 2019-01-25 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N208956-001 10166181 2029-06-30 Drug product 2019-01-25 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N208956-001 10166181 2029-06-30 Drug product 2019-01-25 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N208956-001 10166181 2029-06-30 Drug product 2019-01-25 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N208956-001 10166181 2029-06-30 Drug product 2019-01-25 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N208956-001 10166181 2029-06-30 Drug product 2019-01-25 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N208956-001 10166181 2029-06-30 Drug product 2019-01-25 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N208956-001 10166181 2029-06-30 Drug product 2019-01-25 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N208956-001 10166181 2029-06-30 Drug product 2019-01-25 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N208956-001 10166181 2029-06-30 Drug product 2019-01-25 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N208956-001 10166181 2029-06-30 Drug product 2019-01-25 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N208956-001 10166181 2029-06-30 Drug product 2019-01-25 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N208956-001 10166181 2029-02-10 Drug product 2019-01-25 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N208956-001 10166181 2029-06-30 Drug product 2019-01-25 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N208956-001 10166181 2029-06-30 Drug product 2019-01-25 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N208956-001 10166181 2029-06-30 Drug product 2019-01-25 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N208956-001 10166181 2029-06-30 Drug product 2019-01-25 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N208956-001 10166181 2029-06-30 Drug product 2019-01-25 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N208956-001 10166181 2029-06-30 Drug product 2019-01-25 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N208956-001 10166181 2029-02-10 Drug product 2019-01-25 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N208956-001 10166181 2029-02-10 Drug product 2019-01-25 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N208956-001 10166181 2029-02-10 Drug product 2019-01-25 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N208956-001 10166181 2029-06-30 Drug product 2019-01-25 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N208956-001 10166181 2029-06-30 Drug product 2019-01-25 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N208956-001 10166181 2029-06-30 Drug product 2019-01-25 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N208956-001 10166181 2029-06-30 Drug product 2019-01-25 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N208956-001 10166181 2029-06-30 Drug product 2019-01-25 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N208956-001 10166181 2029-06-30 Drug product 2019-01-25 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N208956-001 10166181 2029-06-30 Drug product 2019-01-25 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N208956-001 10166181 2029-06-30 Drug product 2019-01-25 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N208956-001 10166181 2029-06-30 Drug product 2019-01-25 3bdfa0b2c4d7…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 2 · 41 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 5 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 24338-150 TRIPTODUR triptorelin Arbor Pharmaceuticals, LLC NDA Current 24338-150 TRIPTODUR triptorelin Arbor Pharmaceuticals, LLC NDA Current 24338-150 TRIPTODUR triptorelin Azurity Pharmaceuticals, Inc. NDA Current 24338-150 TRIPTODUR triptorelin Arbor Pharmaceuticals, LLC NDA Current 24338-150 TRIPTODUR triptorelin Arbor Pharmaceuticals, LLC NDA Current